Annual Congress Copenhagen 2005


Material from 2005:
  • 4063 Abstracts
  • 739 Slide presentations
  • 213 Webcasts
  • 93 Handouts
Material from 2005:  Show


Combination therapy for asthma. Which, why and how?

Oral Presentation
Chairs: E. Bateman (Cape Town, South Africa), J. C. Virchow (Rostock, Germany)


Download all media Download all media
 [+]  Slide presentation 2764 The concept study: comparative influence of two treatment strategies on airway response to AMP
L. P. Boulet, J. M. Fitzgerald, W. R. Pieters, R. M. Follows (Quebec, Vancouver, Canada; Helmond, Netherlands; Greenford, United Kingdom)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 No content
  made available
2765 Improved control of symptoms and exacerbations with stable dose treatment with salmeterol/fluticasone propionate (SFC) compared with adjustable maintenace dosing with formoterol/budesonide (FBC)
M. Fitzgerald, L.P. Boulet, W.R. Pieters (Vancouver, Quebec, Canada; Helmond, Netherlands)
 [+]  Congress or journal article abstract 2766 Stable dosing with salmeterol/fluticasone propionate combination ensures long-term asthma control, including airway hyperresponsiveness
B. Lundbäck, E. Rönmark, A. C. Jonsson, L. G. Larsson, A. Linberg, D. H. Richards, M. H. James (Luleä, Stockholm, Sweden; Greenford, United Kingdom)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 2767 Retrospective review of studies shows that patients receiving salmeterol plus ICS have fewer serious asthma exacerbations vs patients on ICS alone, regardless of ethnic origin
P. M. Dorinsky, S. W. Yancey, B. A. Prillaman, L. B. Sutton, J. L. Stauffer (Research Triangle Park, United States Of America)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 2768 Aiming for total control in asthma: an ineffective use of resources?
E. Andreasson, I. Naya (Lund, Sweden)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 2769 Aiming for total control of asthma with salmeterol/fluticasone propionate (SFC), a cost effective option
J. Bousquet, E. Bateman, A. Briggs, T. Clark, S. Pedersen, W. Busse (Montpellier, France; Cape Town, South Africa; Oxford, London, United Kingdom; Madison, United States Of America)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract Slide presentation 2770 Maintenance plus as-needed budesonide/formoterol vs salmeterol/fluticasone in a real-life setting
C. Vogelmeier, A. D‘Urzo (Marburg, Germany; Toronto, Canada)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract Slide presentation 2771 Salmeterol/fluticasone combination product (SFC) provides better asthma control compared to high dose fluticasone (FP) in symptomatic patients with asthma
J. Joshi, K. Jagannath, S. Chabbra, S. Rajan, J. Gogtay, C. J. Po, P. Mahadik, P. Deshpande (Mumbai, India)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite